AI Assistant
Blog
Pricing
Log In
Sign Up
Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.